DTC Staff on Pain Management Programme

DUBAI — Dubai Taxi Corporation (DTC) has teamed up with Novartis Pharmaceuticals (UAE) to set off a medical awareness programme throughout the year, with the aim of promoting health awareness of employees and drivers on pain and pain management.



By Staff Reporter

Published: Tue 19 Jan 2010, 10:42 PM

Last updated: Mon 6 Apr 2015, 2:32 PM

Ammar bin Tameem, Director of DTC Fleet Drivers Affairs Department, said, “In the context of DTC strategy to raise the satisfaction of drivers and educate them on health-related matters contributing to the provision of excellent service, DTC has coordinated with Novartis the staging of an integrated health programme that includes a number of awareness workshops, practical exercises and theoretical lessons for drivers and employees to educate them on various types of backaches and headaches including migraine, exhaustion and fatigue.”

He added, “An hour-long awareness workshop will be organised at DTC every month in cooperation with the Drivers Training and Qualifying Centre at the Fleet Drivers Affairs Department. We can, however, increase the time depending on the extent of benefit derived from the programme and increased turnout by employees and drivers”.

“DTC seeks to provide all the means and services offered to its employees in general and drivers in particular in recognition of their efforts to achieve highest standards of optimal service, out of RTA vision of ‘Safe and Smooth Transport for All’ and their contribution to promoting the business of the RTA and DTC and raising their profile in the community” added Ammar.

For his part, Dr. Ibrahim Aqal, representative of Novartis Pharmaceuticals (UAE), said, “We are happy to have teamed up with DTC in launching this medical awareness programme extending throughout the year and including all its employees and drivers, which aims at promoting awareness and health education on pains, exhaustion, fatigue, risks and consequential health problems”.

Dr. Mohammed Ibrahim, medical advisor at Novartis Middle East, stated that the company was committed to providing all educational material required during awareness workshops to ensure delivery and comprehension of the messages and attaining maximum benefit from the initiative.

He emphasised that this programme would be evaluated towards its end to measure the extent of success made, and make any additions, amendments or observations for implementation in similar other programmes and accordingly improve the company’s health projects.


More news from